Shiv Pillai, Published , 2023 – More infoView PDF , 10.1172/JCI168080 Abstract The continued emergence of SARS-CoV-2 variants and waning vaccine immunity are some of the factors that drive the continuing search […]
The intersection of COVID-19 and autoimmunity
Jason S. Knight,1 Roberto Caricchio,2 Jean-Laurent Casanova,3,4,5,6 Alexis J. Combes,7 Betty Diamond,8 Sharon E. Fox,9,10 David A. Hanauer,11 Judith A. James,12 Yogendra Kanthi,13 Virginia Ladd,14 Puja Mehta,15 Aaron M. Ring,16 Ignacio Sanz,17 Carlo Selmi,18,19 Russell P. Tracy,20 Paul J. Utz,21 Catriona A. Wagner,14 Julia Y. Wang,22 and William J. […]
Excess Deaths Associated with COVID-19
Provisional Death Counts for COVID-19 NOTICE: THIS WEBSITE WAS ARCHIVED ON SEPTEMBER 27, 2023.Datasets linked on this page are available on data.cdc.gov. Please note that these datasets will no longer […]
COVID Pandemic Caused Collective Trauma in Americans, Survey Says
Americans are more stressed than before, and experts blame COVID Published 11/03/23, Mansur Shaheen, The Messenger COVID Pandemic Caused Collective Trauma in Americans, Survey Says Americans, and specifically younger people, […]
Ventilator-associated pneumonia in ICU patients with severe pneumonia and respiratory failure
Sarah Jackson Published June 15, 2023 – 10.1172/JCI172643 The Journal of Clinical Medicine The COVID-19 pandemic resulted in an unprecedented number of patients hospitalized in intensive care units (ICUs) because of […]
No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines
Natalie E. Stevens,1,2 Feargal J. Ryan,1,2 Nicole L. Messina,3,4 Stephen J. Blake,1,2 Todd S. Norton,1 Susie Germano,3 Jane James,1 Georgina L. Eden,1 Yee C. Tee,1,2 Miriam A. Lynn,1,2 Rochelle Botten,1 Simone E. Barry,5 Nigel Curtis,3,4 and David J. Lynn1,2 Published July 20, 2023 – September […]
Systemic and organ-specific immune-related manifestations of COVID-19
Manuel Ramos-Casals, Pilar Brito-Zerón & Xavier Mariette Nature Reviews Rheumatology volume 17, pages315–332 (2021) Cite this article Abstract Immune-related manifestations are increasingly recognized conditions in patients with COVID-19, with around 3,000 cases reported worldwide comprising more than […]
COVID-19 Therapeutics for Nonhospitalized Patients
Rajesh T. Gandhi, MD1; Preeti N. Malani, MD, MSJ2,3; Carlos del Rio, MD4, JAMA. 2022;327(7):617-618. doi:10.1001/jama.2022.0335 Substantial progress has been made in therapeutics for nonhospitalized patients with COVID-19, but supply of and access to treatment remain limited. This Viewpoint […]
US Survey: About 7% of Adults, 1% of Children Have Had Long COVID
Emily Harris, JAMA. 2023;330(16):1516. doi:10.1001/jama.2023.19208 Medical News in Brief October 2023 JAMA Network More than 3% of US adults had post–COVID-19 condition, or long COVID, at the time of a 2022 National […]
Hydroxychloroquine Associated With Lower COVID-19 Mortality: French Study
NOV 03, 2023 – Authored by Zachary Stieber The Epoch Times People who received hydroxychloroquine were less likely to die than those who did not, according to a new study. […]